Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns

Breast Cancer Research and Treatment

Volumn 142, Issue 2, 2013, Pages 365-380

  Bardowell, Sabrina A ^a   Parker, Joel ^a,b   Fan, Cheng ^a   Crandell, Jamie ^a   Perou, Charles M ^a,b   Swift Scanlan, Theresa ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Basal like; BRCA1; Breast cancer; Epigenetic; Illumina; Methylation

Indexed keywords

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; KR5 GENE; KRT17 GENE; MIA GENE; PHGDH GENE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84890430546     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2738-0     Document Type: Article

References (25)

1. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10:687-692
2. Belinsky SA (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nature reviews. Cancer 4:707-717. doi: 10.1038/nrc1432
3. Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61-70. doi: 10.1038/nature11412
4. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35:e119. doi: 10.1093/nar/gkm662
5. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632-4642. doi: 10.1200/JCO.2004.07.151
6. Ehrich M, Bocker S, van den Boom D (2005) Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res 33:e38. doi: 10.1093/nar/gni038
7. Esteller M, Herman JG (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196:1-7. doi: 10.1002/path.1024
8. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S (2006) Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 12:3306-3310. doi: 10.1158/1078-0432.CCR-05-2733
9. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447:433-440. doi: 10.1038/nature05919
10. Gardner KE, Allis CD, Strahl BD (2011) Operating on chromatin, a colorful language where context matters. J Mol Biol 409:36-46. doi: 10.1016/j.jmb.2011. 01.040
11. Hasan TN, Leena Grace B, Shafi G, Syed R (2013) Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer. Clin Transl Oncol 15:555-562. doi: 10.1007/s12094-012-0968-y
12. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jonsson G, Olsson H, Borg A, Ringner M (2010) Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res 12:R36. doi: 10.1186/bcr2590
13. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96. doi: 10.1186/1471-2164-7-96
14. Lu Y, Chu A, Turker MS, Glazer PM (2011) Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol 31:3339-3350. doi: 10.1128/MCB.01121-10
15. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160-1167. doi: 10.1200/JCO.2008.18.1370
16. Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W, Zhong XY (2009) Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Oncogene 28:2969-2978. doi: 10.1038/onc.2009.149
17. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J (2006) TM4 microarray software suite. Methods Enzymol 411:134-193. doi: 10.1016/S0076-6879(06)11009-5
18. Stefansson OA, Jonasson JG, Olafsdottir K, Hilmarsdottir H, Olafsdottir G, Esteller M, Johannsson OT, Eyfjord JE (2011) CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics 6:638-649. doi: 10.4161/epi.6.5.15667
19. Suijkerbuijk KP, Fackler MJ, Sukumar S, van Gils CH, van Laar T, van der Wall E, Vooijs M, van Diest PJ (2008) Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol 19:1870-1874. doi: 10.1093/annonc/mdn409
20. Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S (2011) Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther 11:853-865
21. Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T (2013) Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Res Treat 137:383-396. doi: 10.1007/s10549-012-2353-5
22. Wilcox CB, Baysal BE, Gallion HH, Strange MA, DeLoia JA (2005) High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors. Cancer Genet Cytogenet 159:114-122. doi: 10.1016/j.cancergencyto.2004.12.017
23. Wu JM, Fackler MJ, Halushka MK, Molavi DW, Taylor ME, Teo WW, Griffin C, Fetting J, Davidson NE, De Marzo AM, Hicks JL, Chitale D, Ladanyi M, Sukumar S, Argani P (2008) Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res 14:1938-1946. doi: 10.1158/1078-0432.CCR-07-4082
24. Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J, Slamon DJ, Olopade OI (2010) CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast Cancer Res Treat 120:593-601. doi: 10.1007/s10549-009-0422-1
25. You JS, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22:9-20. doi: 10.1016/j.ccr.2012.06.008